Institut Pasteur-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Institut Pasteur - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014020
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institut Pasteur is a non-profit foundation that provides research, health services and education. The institute offers research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology and chemistry, and virology, among others. It provides health services through its medical centers having vaccination center and outpatient department. Institut Pasteur offers educational services including Institut Pasteur courses, international network courses and doctoral programs. The institute partners with research institutes, private foundations, international organizations, universities academic organizations, associations, and bilateral and multilateral initiatives. Institut Pasteur is headquartered in Paris, France.

Institut Pasteur – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Pasteur, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Pasteur, Medical Devices Deals, 2011 to YTD 2017 9
Institut Pasteur, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Pasteur, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
MRC Technology Enters into Co-Development Agreement with IPS-CAS 13
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 14
Institut Pasteur Korea Enters into Research Agreement with DNDi 15
Ferring Pharma Partners with Institut Pasteur 16
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 17
Institut Pasteur Korea and DNDi Enter into Research Agreement 18
Amsterdam Molecular Therapeutics Enters Into An Agreement With Institut Pasteur And The Consortium 19
Licensing Agreements 20
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 20
Institut Pasteur Enters into Licensing Agreement with Stragen Pharma 21
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 22
Bluebird bio Amends its Licensing Agreement with Institut Pasteur 23
Institut Pasteur Enters Into Licensing Agreement With Stragen Pharma For Opiorphin 24
Institut Pasteur – Key Competitors 25
Institut Pasteur – Key Employees 26
Institut Pasteur – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Government and Public Interest 29
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 29
Aug 29, 2016: Alzheimer’s: Nicotinic receptors as a new therapeutic target 31
Other Significant Developments 32
Sep 07, 2016: Myriad RBM’s TruCulture and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Institut Pasteur, Pharmaceuticals & Healthcare, Key Facts 2
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Pasteur, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Pasteur, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Pasteur, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Pasteur, Medical Devices Deals, 2011 to YTD 2017 9
Institut Pasteur, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
MRC Technology Enters into Co-Development Agreement with IPS-CAS 13
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 14
Institut Pasteur Korea Enters into Research Agreement with DNDi 15
Ferring Pharma Partners with Institut Pasteur 16
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 17
Institut Pasteur Korea and DNDi Enter into Research Agreement 18
Amsterdam Molecular Therapeutics Enters Into An Agreement With Institut Pasteur And The Consortium 19
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 20
Institut Pasteur Enters into Licensing Agreement with Stragen Pharma 21
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 22
Bluebird bio Amends its Licensing Agreement with Institut Pasteur 23
Institut Pasteur Enters Into Licensing Agreement With Stragen Pharma For Opiorphin 24
Institut Pasteur, Key Competitors 25
Institut Pasteur, Key Employees 26
Institut Pasteur, Subsidiaries 27

★海外企業調査レポート[Institut Pasteur-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Inova Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include quanta flash used for semi-quantitative determination of aut …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務情報
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enercon GmbH:企業の戦略的SWOT分析
    Enercon GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • GE Lighting LLC:企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • SEEK Limited:企業のM&A・事業提携・投資動向
    SEEK Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEEK Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Cadila Healthcare Ltd (CADILAHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health product …
  • Tokio Marine Holdings, Inc.:戦略・SWOT・企業財務分析
    Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PharmaLundensis AB:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • Voltamp Transformers Ltd (VOLTAMP):企業の財務・戦略的SWOT分析
    Voltamp Transformers Ltd (VOLTAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ssr Mining Inc:企業の戦略・SWOT・財務分析
    Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Ssr Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dow Silicones Corp:企業の戦略的SWOT分析
    Dow Silicones Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Martinrea International Inc:企業の戦略・SWOT・財務情報
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PetroChina Company Limited:企業の戦略・SWOT・財務情報
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Welltower Inc
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nippon Paint (China) Co Ltd:企業の戦略・SWOT・財務情報
    Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Paint (China) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kuros Biosciences AG (KURN):医療機器:M&Aディール及び事業提携情報
    Summary Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as we …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable), a subsidiary of Eurocom Group, is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by whi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆